Justin Sullivan Investment Thesis The challenges for retail pharmacy giant Walgreens Boots Alliance, Inc. (NASDAQ:WBA) are profound, with lower demand from consumers seeking vaccinations and testing for COVID-19 on one hand and tight reins on prescription drug payouts hobbling its operations. But most crucially, the company's assertive push into other healthcare businesses faces a few sticking points that show catching up might take some time. Over the past three years, Walgreens has lost nearly 60% in ...

The market expects Walgreens Boots Alliance (WBA) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended February 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on March 28, 2024, might help the stock move higher if these key ...

Walgreens Boots Alliance, Inc. (WBA) wholly-owned subsidiary — AllianceRx Walgreens Pharmacy — is selected as the exclusive distributor of Mycovia Pharmaceuticals’ VIVJOA (oteseconazole). Walgreens specialty pharmacy patients now have exclusive access to 240+ limited distribution drugs, which are available through Walgreens specialty pharmacy.The latest development will bolster Walgreens’ Speciality Pharmacy business.More on the NewsMycovia Pharmaceuticals’ VIVJOA is the first FDA-approved medicine to minim ...

Walgreens confirmed it was closing distribution centers in Florida and Connecticut that employ more ... [+] than 600 combined at the two facilities, the company said March 18, 2024. In this photo, a worker makes deliveries as a truck sits parked outside a Walgreens Boots Alliance Inc. store in Los Angeles, California, U.S., on Friday, Oct. 20, 2017. Photographer: Christopher Lee/Bloomberg© 2017 Bloomberg Finance LPWalgreens Boots Alliance chief executive officer Tim Wentworth is continuing his effort to tur ...

Justin Sullivan Sentiment reached negative extreme The sentiment surrounding Walgreens Boots Alliance (NASDAQ:WBA) has now reached an extreme in my view - and for many good reasons. As seen in the next chart, neither Main Street (approximated by Seeking Alpha writers) nor Wall Street analysts like the stock. To wit, among the 10 Seeking Alpha analyses published on the ticker in the past 90 days, no one rated it as a strong buy, and it received an average rating of 3.44. On Wall Street's side, 20 analysts co ...

Walgreens Boots Alliance (WBA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this largest U.S. drugstore chain have returned -2.3% over the past month versus the Zacks S&P 500 composite's +4.4% change. The Zacks Retail - Pharmacies and Drug Stores industry, to which Walgreens belongs, has lost 2% over this period. Now the key question is: Where could th ...

The latest trading session saw Walgreens Boots Alliance (WBA) ending at $21.28, denoting a -1.21% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 1.12%. At the same time, the Dow added 0.61%, and the tech-heavy Nasdaq gained 1.54%.The largest U.S. drugstore chain's stock has dropped by 4.82% in the past month, falling short of the Retail-Wholesale sector's gain of 1.42% and the S&P 500's gain of 2.06%.Market participants will be closely following the financ ...

Walgreens is adding Claire’s products to its stores, a move that comes as pharmacy chains look to grow their relevance in consumers’ day-to-day lives.Claire’s, known for its accessories and cosmetics for young consumers, will now have a dedicated presence within Walgreens stores, arriving at more than 4,400 of the retailer’s locations by the end of the month, the fashion brand announced Tuesday (March 12).“Walgreens is proud to offer a wide assortment of must haves for its customers,” Walgreens Group Vice P ...

Walgreens Boots Alliance, Inc. (WBA) is well poised to grow in the coming quarters, backed by its continued partnership growth and a strong focus on strategic execution. The company’s long-term growth model looks encouraging. However, weak margins and stiff rivalry do not bode well.In the past year, the Zacks Rank #3 (Hold) stock has declined 1.6% compared with a 12.3% rise of the industry and a 12.4% rise of the S&P 500.The renowned pharmacy-led health and beauty retail company has a market capitalization ...

Walgreens Boots Alliance (WBA) ended the recent trading session at $20.89, demonstrating a -0.57% swing from the preceding day's closing price. This change lagged the S&P 500's 0.51% gain on the day. Elsewhere, the Dow saw an upswing of 0.2%, while the tech-heavy Nasdaq appreciated by 0.58%.The the stock of largest U.S. drugstore chain has fallen by 9.09% in the past month, lagging the Retail-Wholesale sector's gain of 4.13% and the S&P 500's gain of 2.94%.Analysts and investors alike will be keeping a clos ...